Social Security Trust Fund Faces Depletion By 2032, Threatening 22% Cut To Retiree Benefits

The Social Security retirement trust fund is now projected to be depleted in the fourth quarter of 2032, according to the latest trustees’ report released Tuesday. That date is several months earlier than last year’s estimate, reflecting a notable acceleration in the program’s financial deterioration. Once the trust fund is exhausted, Social Security would only…

Read More

Apple (AAPL) AI Upgrade Cycle Gains Steam As New Siri Demands More Powerful Hardware

Apple’s next-generation Siri assistant will require at least 12 gigabytes of unified memory to run, setting the stage for a sweeping device upgrade cycle. The memory requirement effectively locks out millions of existing iPhone and Mac users from accessing Apple’s most advanced AI features without purchasing new hardware. Analysts and market observers believe this hardware…

Read More

SpaceX IPO Creates New Challenges For ETFs (BPTIX, RONB, XOVR, NASA) That Rode Early Stakes Higher

Several exchange-traded funds that built early private-market positions in SpaceX have seen dramatic asset growth ahead of the company’s highly anticipated public listing. Four funds in particular attracted a combined $7.9 billion in net inflows due to their existing private SpaceX holdings, signaling enormous investor appetite for pre-IPO exposure. The funds drawing the most attention…

Read More

GSK (GSK) Seals $10.6 Billion Nuvalent Acquisition In Largest Deal For Cancer Portfolio In Over A Decade

British drugmaker GSK has agreed to acquire U.S.-listed oncology specialist Nuvalent in an all-cash deal valued at $10.6 billion. The transaction values Boston-based Nuvalent at approximately $124 per share, representing a 40% premium to its last closing price. Net of cash acquired, GSK’s aggregate investment is estimated at $9.4 billion, with the deal primarily funded…

Read More